Literature DB >> 23919974

Anaesthesia with medetomidine-ketamine-isoflurane with and without midazolam, in eight captive chimpanzees (Pan troglodytes) premedicated with oral zuclopenthixol.

C Adami1, C Wenker, S Hoby, U Morath, A Bergadano.   

Abstract

In 8 captive adult chimpanzees of various ages premedicated with oral zuclopenthixol anaesthesia was induced intramuscularly with a combination of medetomidine and ketamine (40 or 50 µg/kg and 5 mg/kg, IM, respectively), with and without midazolam (0.05 mg/kg), and maintained with isoflurane in oxygen. At the end of the procedure, sedation was reversed with atipamezole (0.25 mg/kg, IM) and sarmazenil (0.005 mg/kg, IM) when midazolam had been administered. Oral zuclopenthixol resulted in tranquillization of the whole group and only one animal required a second dart injection to achieve adequately deep anaesthesia. Effective and reliable anaesthesia was achieved in all apes; the depth of hypnosis was stable and sudden arousal did not occur. Physiological parameters remained within normal ranges in the majority of the animals; however, manageable anaesthesia-related complications, namely apnoea after darting, hypotension, hypoventilation, hypoxemia and prolonged recovery, occurred in 6 out of 8 animals. The use of monitoring devices was essential to guarantee adequate management of these complications.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23919974     DOI: 10.1024/0036-7281/a000493

Source DB:  PubMed          Journal:  Schweiz Arch Tierheilkd        ISSN: 0036-7281            Impact factor:   0.845


  2 in total

Review 1.  Anesthetizing animals: Similar to humans yet, peculiar?

Authors:  Madhuri S Kurdi; Ashwini H Ramaswamy
Journal:  Anesth Essays Res       Date:  2015 Sep-Dec

2.  Propofol infusions using a human target controlled infusion (TCI) pump in chimpanzees (Pan troglodytes).

Authors:  T Miyabe-Nishiwaki; A Kaneko; A Yamanaka; N Maeda; J Suzuki; M Tomonaga; T Matsuzawa; K Muta; R Nishimura; I Yajima; D J Eleveld; A R Absalom; K Masui
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.